4//SEC Filing
Gionco David 4
Accession 0001104659-19-011258
CIK 0001264587other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 9:10 PM ET
Size
5.7 KB
Accession
0001104659-19-011258
Insider Transaction Report
Form 4
Gionco David
Chief Accounting Officer
Transactions
- Sale
Common Stock
2019-02-25$12.03/sh−8,563$103,013→ 240,341 total
Footnotes (3)
- [F1]In connection with the vesting of 18,006 shares on February 24, 2019, a total of 8,563 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
- [F2]Reflects the weighted average sale price. The range of prices for such transaction is $12.00 to $12.06. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Of the 240,341 shares, 204,770 shares are restricted stock.
Documents
Issuer
STEMLINE THERAPEUTICS INC
CIK 0001264587
Entity typeother
Related Parties
1- filerCIK 0001456864
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 9:10 PM ET
- Size
- 5.7 KB